IRIS
BASSETTI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 28.420
Totale 28.420
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 28.420
Totale 28.420
Salva come PNG Salva come JPEG
Città #
Genova 21.977
Rapallo 3.556
Genoa 2.774
Bordighera 113
Totale 28.420
Salva come PNG Salva come JPEG
Nome #
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 240
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 166
Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals. 158
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 139
An Italian consensus for invasive candidiasis management (ITALIC). 137
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 136
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 134
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. 132
Invasive candidiasis in non-hematological patients. 132
Possible malignant transformation of benign lymphoepithelial parotid lesions in human immunodeficiency virus-infected patients: report of three cases. 132
Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital. 130
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 130
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 128
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 127
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 126
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 126
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 125
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment 123
Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy 121
Candidaemia in internal medicine departments: the burden of a rising problem. 120
Primary varicella zoster infection associated with fingolimod treatment. 119
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 119
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 119
Use of colistin in adult patients: a cross-sectional study 119
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 118
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration 117
Will new antimicrobials overcome resistance among Gram-negatives? 116
Infective endocarditis in elderly: An Italian prospective multi-center observational study 116
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 116
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 115
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies 115
High-dose daptomycin in documented Staphylococcus aureus infections. 115
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 114
Management of KPC-producing Klebsiella pneumoniae infections 114
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). 112
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. 112
Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children 111
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 111
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 110
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 109
Monitoraggio della gestione pre ed intra-operatoria del paziente sottoposto ad intervento chirurgico presso l’A.O.U. San Martino di Genova 107
Sequentialoutbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation 107
Treatment of Infections Due to MDR Gram-Negative Bacteria 107
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 107
Tigecycline use in serious nosocomial infections: a drug use evaluation. 107
Pseudomonas aeruginosa serious infections: mono or combination antimicrobial therapy? 106
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 106
Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy 104
null 102
Antimicrobial use and resistance among gram-negative bacilli in an italian intensive care unit (ICU) 101
Novel beta-lactam antibiotics and inhibitor combinations. Expert Opin Investig Drugs 101
Current status of newer carbapenems 101
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. 100
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study-authors' response 100
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 100
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 100
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. 99
Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies 99
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 99
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 99
Hospital-Acquired Infections and Leading Pathogens Detected in a Regional University Adult Acute-care Hospital in Genoa, Liguria, Italy: Results from a Prevalence Study 98
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 98
Risk factors andmortality of healthcare-associated and community-acquired Staphylococcus aureusbacteraemia 97
Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects 97
Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort. 97
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 97
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B 96
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 96
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections 96
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 96
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 96
A case report of Absidia corymbifera soft-tissue infection with kidney involvement in a AIDS patient. 95
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 95
Clinical and therapeutic aspects of candidemia: A five year single centre study 95
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients 95
Epidemiological trends in nosocomial candidemia in intensive care 94
Soft-tissue infection with Absidia corymbifera and kidney complications in an AIDS patient. 94
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 94
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae 94
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 93
Analysis of clinical data in patients with Girldstone arthroplasty: a new score 92
Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study 92
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 92
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections 91
Why is community-associated MRSA spreading across the world and how will it change clinical practice? 90
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 90
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 90
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. 89
Predictors of Mortality in Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae: Importance of Combination Therapy. 89
Ceftolozane/tazobactam: place in therapy 89
New treatment options against gram-negative organisms. 88
The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts 88
Benign lymphoepithelial parotid lesions in vertically HIV-infected patients 88
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. 87
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 86
Dose finding in aspergillosis 86
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumba 86
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 85
Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults 85
Does the adoption of EUCAST susceptibility breackpoints affects the selection of antimicrobials to treat acute community-acquired respiratory tract infections? 84
Totale 10.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.928
article - articoli 106.689
book - libri 0
conference - conferenze 530
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 709
Totale 215.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019748 0 0 0 0 0 0 0 0 0 145 316 287
2019/20209.758 225 98 161 260 521 695 1.807 1.196 1.421 1.891 1.083 400
2020/20214.617 219 562 454 365 359 288 283 509 359 639 254 326
2021/20225.255 247 176 191 536 167 382 385 1.166 645 429 266 665
2022/20234.523 557 326 55 381 574 601 139 313 818 215 439 105
2023/20242.076 137 326 79 319 234 410 185 181 152 53 0 0
Totale 29.580